publications

Dr. Riordan has co-authored 55 publications to date. As a company, we pride ourselves in the research behind our products. Dr. Riordan has been significantly involved with research from alternative cancer therapies to stem cell therapies for various degenerative conditions. Most of the full articles are available for free in pdf format below. On the left, you will see links to articles which are directly associated with our products.

  • Increased Level of Circulating Endothelial Microparticles and Cardiovascular Risk Factors

  • Intravenous ascorbic acid to prevent and treat cancer-associated sepsis?

  • On the missing link between inflammation and cancer

  • Cutaneous sarcoidosis and malignancy: An association between sarcoidosis with skin manifestations and systematic neoplasia

  • Outstanding survival and regeneration process by the use of intelligent acellular dermal matrices and mesenchymal stem cells in a burn pig model

  • Prevention of hyperglycemia-induced myocardial apoptosis by gene silencing of Toll-like receptor-4

  • Feasibility of combination allogeneic stem cell therapy for spinal cord injury: a case report

  • Vitamin D concentrations, endothelial progenitor cells, and cardiovascular risk factors

  • Circulating endothelial progenitor cells and erectile dysfunction: possibility of nutritional intervention?

  • Safety evaluation of allogeneic umbilical cord blood mononuclear cell therapy for degenerative conditions

  • Immunotherapy for melanoma: curennt status and perspectives

  • Autologous stromal vascular fraction cells: a tool for facilitating tolerance in rheumatic disease

  • Tumor vaccines in 2010: need for integration

  • Combination stem cell therapy for heart failure

  • Nutraceutical augmentation of circulating endothelial progenitor cells and hematopoietic stem cells in human subjects

  • The lysosomotropic agent, hydroxychloroquine, delivered in a biodegradable nanoparticle system, overcomes drug resistance of B-chronic lymphocytic leukemia cells in vitro

  • The next generation of burns treatment: intelligent films and matrix, controlled enzymatic debridement, and adult stem cells

  • Ascorbate inhibition of angiogenesis in aortic rings ex vivo and subcutaneous Matrigel plugs in vivo

  • Circulating endothelial progenitor cells: a new approach to anti-aging medicine?

  • Mesenchymal stem cells as anti-inflammatories: implications for treatment of Duchenne muscular dystrophy

  • Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis

  • Feasibility investigation of allogeneic endometrial regenerative cells

  • Inhibition of intracranial glioma growth by endometrial regenerative cells

  • Anti-angiogenic effect of high doses of ascorbic acid

  • Allogeneic endometrial regenerative cells: an "Off the shelf solution" for critical limb ischemia?

  • Granulocyte activity in patients with cancer and healthy subjects

  • Exosomes as a tumor immune escape mechanism: possible therapeutic implications

  • Immune effects of mesenchymal stem cells: implications for Charcot-Marie-Tooth disease

  • Placental mesenchymal and cord blood stem cell therapy for dilated cardiomyopathy

  • Pharmacokinetics of vitamin C: insights into the oral and intravenous administration of ascorbate

  • Antigen-specific therapy of rheumatoid arthritis

  • Endometrial regenerative cells: a novel stem cell population

  • Stem cell therapy for autism

  • Vitamin C pharmacokinetics after continuous infusion in a patient with prostate cancer

  • Cord blood in regenerative medicine: do we need immune supression?

  • Therapeutic use of Aldara in chronic myeloid leukemia

  • Tumor growth parameters of in-vivo human breast carcinoma: a proposed mathematical model for tumor growth kinetics

  • Induction of antitumor immunity through xenoplacental immunization

  • A pilot clinical study of continuous intracenous ascorbate in terminal cancer patients

  • A novel method of modifying immune responses by vaccination with lipiodol-siRNA mixtures

  • Cancer is a functional repair tissue

  • Orthomolecular oncology review: ascorbic acid and cancer 25 years later

  • Intravenous vitamin C as a chemotherapy agent: a report on clinical cases

  • Cell membrane fatty acid composition differs between normal and malignant cell lines

  • L-ascorbic acid represses constitutive activation of NF-kappaB and COX-2 expression in human acute myeloid leukemia, HL-60

  • Intravenous ascorbic acid: protocol for its application and use

  • Prevention of venous thrombosis in long-haul flights with Flite Tabs: the LONFLITE-FLITE randomized, controlled trial

  • Effects of a high molecular mass Convolvulus arvensis extract on tumor growth and angiogenesis

  • Orthomolecular oncology: a mechanistic view of intravenous ascorbate's chemotherapeutic activity

  • Inhibition of human breast carcinoma cell proliferation by ascorbate and copper

  • Cytotoxicity of ascorbate, liopic acid, and other antioxidants in hollow fibre in vitro tumours

  • Integrative medicine: a paradigm shift in medical education and practice

  • The paradoxical role of lipid peroxidation on carcinogenesis and tumor growth: a commentary

  • Intravenous ascorbate as a tumor cytotoxic chemotherapeutic agent

  • Improved microplate fluorometer counting of viable tumor and normal cells